Topchoice Medical Co., Inc. (SHA:600763)
China flag China · Delayed Price · Currency is CNY
35.62
+1.41 (4.12%)
Oct 30, 2026, 2:45 PM CST

Topchoice Medical Co. Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,0492,9132,8742,8472,7192,781
Revenue Growth
1.44%1.37%0.96%4.70%-2.23%33.18%
Gross Profit
1,2111,1251,1071,0971,1101,281
Operating Income
772.99693.72690.92694.35734.97929.37
Net Income
634.11501.95501500.44548.27702.81
Earnings Per Share
1.421.121.121.121.221.56
EPS Growth
17.31%0%0%-8.26%-21.92%42.21%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Management Services and Others
126.63194.7145.06137.990.79
Intersegment elimination
-229.11-213.86-174.96-204.21-
Medical Services
2,7842,7602,7092,5932,632
Sales Products
231.11133.38167.34192.28125.28
Total
2,9132,8742,8472,7192,758

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
619.84698.64621.98594.48630.32843.99
Total Debt
1,2351,1121,4451,4591,1541,299
Net Cash (Debt)
-614.81-413.56-822.56-864.77-523.63-455.02
Net Cash Growth
------
Net Cash Per Share
-1.38-0.92-1.84-1.94-1.17-1.01

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
898.19810.72762.99841.02670.05939.41
Capital Expenditures
-205.07-246.2-332.11-508.9-421.53-367.32
Free Cash Flow
693.11564.52430.88332.13248.52572.09
Free Cash Flow Growth
27.27%31.02%29.73%33.64%-56.56%6.33%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.71%38.63%38.51%38.53%40.81%46.06%
Operating Margin
25.35%23.81%24.04%24.39%27.03%33.42%
Pretax Margin
28.83%24.21%24.14%24.90%27.15%35.05%
Profit Margin
20.80%17.23%17.43%17.58%20.17%25.27%
FCF Margin
22.73%19.38%14.99%11.67%9.14%20.57%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingOct '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
0.450-0.4500.311
Dividend Per Share Growth
--44.70%-
Dividend Yield
1.26%-1.01%0.57%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
25.1035.8339.6448.9889.4790.79
Forward PE
23.3737.4346.1429.2176.1575.61
P/FCF Ratio
22.0831.8646.0973.81197.39111.53
PS Ratio
5.026.176.918.6118.0422.95